The United Laboratories International Holdings Limited
ULIHF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.86B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.86 Billion |
|---|---|
| Enterprise Value | $-3,918,226,180.00 |
| Annual dividend | $0.04 |
| Dividend yield | 4.38% |
| Earnings per Share | $1.05 |
| Beta | 0.29 |
| Outstanding Shares | 1,972,631,000 |
Return
| Return on Equity | 20.92% |
|---|---|
| Return on Assets | 11.22% |
| Return on Invested Capital | 17.22% |
Valuation & Multiples
| P/E Ratio | 20.85 |
|---|---|
| PEG | -25.54 |
| Price to Sales | 0.07 |
| Price to Book Ratio | 0.12 |
| Enterprise Value to Revenue | 0.3 |
| Enterprise Value to EBIT | 1.98 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.77 |
| Debt to Equity | 0.35 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
$0.02
Consensus analyst estimateRevenue Estimate
$818.72 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 30, 2027
EPS Estimate
$0.03
Consensus analyst estimateRevenue Estimate
$924.79 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About The United Laboratories International Holdings Limited
18,000 employees
CEO: Hoi Shan Tsoi
The United Laboratories International Holdings Limited functions as an investment holding company with a primary focus on the pharmaceutical sector. Its multifaceted operations cover the entire lifecycle of drug development and commercia...